Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

In response to the FDA warning about the use of photomedicine in gynecology

Academic Article
Publication Date:
2019
abstract:
To alert patients and health care providers about the use of energy-based devices to perform a vaginal “rejuvenation,” cosmetic vaginal procedures, or nonsurgical vaginal procedures to treat symptoms related to menopause, urinary incontinence, or sexual function, the US Food and Drug Administration (FDA) has issued a warning about the effectiveness and safety of such devices. We agree with the FDA that certain devices (laser, radiofrequency, etc.) have been marketed inappropriately for uses that are outside of their cleared or approved intended uses. We want to position ourselves in the strict training of professionals so that the indications and techniques are used in the best possible way, knowing that, similar to any medical or surgical technique, the side effects can appear in the short and long term, and should be recognized and remedied.
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
Keywords:
Energy-based devices; FDA safety communication; Vaginal cosmetic procedures; Vaginal ‘rejuvenation’; Humans; Laser Therapy; Practice Guidelines as Topic; Radiofrequency Therapy; United States; Gynecology; Phototherapy; United States Food and Drug Administration
List of contributors:
Escribano, J. J.; Gonzalez-Isaza, P.; Tserotas, K.; Athanasiou, S.; Zerbinati, N.; Leibaschoff, G.; Salvatore, S.; Sanchez-Borrego, R.
Authors of the University:
SALVATORE STEFANO
Handle:
https://iris.unisr.it/handle/20.500.11768/133158
Published in:
LASERS IN MEDICAL SCIENCE
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.1.0